Cumberland Pharmaceuticals CPIX Vaprisol — Non-current inventories
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cumberland Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNoncurrent.
The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cumberland Pharmaceuticals's vaprisol — non-current inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cumberland Pharmaceuticals's vaprisol — non-current inventories?
- Cumberland Pharmaceuticals (CPIX) reported vaprisol — non-current inventories of $1.17M in Q1 2026.
- How has Cumberland Pharmaceuticals's vaprisol — non-current inventories changed year-over-year?
- Cumberland Pharmaceuticals's vaprisol — non-current inventories decreased by 0.1% year-over-year, from $1.17M to $1.17M.
- What does vaprisol — non-current inventories mean?
- This metric captures the value of inventory associated with a specific product line that is not expected to be sold or consumed within the standard twelve-month operating cycle. It reflects long-term supply chain positioning and potential obsolescence risks for specialized pharmaceutical assets. High levels may indicate strategic stockpiling or, conversely, a slowdown in the product's commercial lifecycle.